NASHUA, N.H.–(BUSINESS WIRE)–iCAD, Inc., (Nasdaq:ICAD), an industry-leading provider of
advanced image analysis, workflow solutions and radiation therapy for
the identification and treatment of cancer, today announced that its
mammography Computer Aided Detection (CAD) solution is now available on
Fujifilm’s Aspire Cristalle full field digital mammography system.
“iCAD is pleased to provide our leading mammography CAD solution to
Fujifilm’s Aspire Cristalle customers worldwide. We trust our integrated
solutions will now provide radiologists with a clinical decision support
tool designed to help provide the highest quality care for mammography
patients,” said Diane Clifford, director of marketing for cancer
detection solutions at iCAD.
The PowerLook Advanced Mammography Platform is a flexible solution
supporting iCAD’s industry leading computer-aided detection algorithm
for digital mammography that assists radiologists in the detection of
breast cancer. The iCAD solution is used by more than 3,000 mammography
“Fujifilm is happy to have reached this important milestone with iCAD,
moving our customers another important step forward with the ability to
simplify the reading of digital mammography exams,” said Rob Fabrizio,
director of marketing and product development at FUJIFILM Medical
Systems U.S.A., Inc. “We trust our customers will be pleased with this
coupling of the most requested CAD platform with the exceptional imaging
capabilities of our Aspire Cristalle mammography system.”
Fujifilm is constantly working to develop the most advanced digital
mammography systems, to assist in the early detection of breast cancer.
Aspire Cristalle brings together Fujifilm’s extensive research,
expertise and experience. The unique platform allows easy upgradability
to future technologies, while offering optimal imaging of all breast
types at lower dose. The Aspire Cristalle will be on display at the
National Consortium of Breast Centers (NCoBC) conference from April
9-13, 2016 in Las Vegas, NV.
For more information, please visit www.fujifilmhealthcare.com.
About iCAD, Inc.
iCAD delivers innovative cancer detection and radiation therapy
solutions and services that enable clinicians to find and treat cancers
earlier and faster while improving patient outcomes. iCAD offers a
comprehensive range of upgradeable computer aided detection (CAD) and
workflow solutions to support rapid and accurate detection of breast,
prostate and colorectal cancers. iCAD’s Xoft® Axxent® Electronic
Brachytherapy (eBx®) System® is a painless, non-invasive technology that
delivers high dose rate, low energy radiation, which targets cancer
while minimizing exposure to surrounding healthy tissue. The Xoft System
is FDA cleared, CE marked, and licensed in a growing number of countries
for the treatment of cancer anywhere in the body, including treatment of
early-stage breast cancer, gynecological cancers and non-melanoma skin
cancer. The comprehensive iCAD technology platforms include advanced
hardware and software as well as management services designed to support
cancer detection and radiation therapy treatments. For more information,
visit or www.icadmed.com
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of
diagnostic imaging products and medical informatics solutions to meet
the needs of healthcare facilities today and well into the future. From
an unrivaled selection of digital x-ray systems, to the Synapse® brand
of PACS, RIS and cardiovascular products, to advanced women’s health
imaging systems, Fujifilm has products that are ideal for any size
imaging environment. The Endoscopy Division of FUJIFILM Medical Systems
U.S.A., Inc. supplies high quality, technologically advanced endoscopes
to the medical market. The TeraMedica Division delivers healthcare
informatics, and is the leading provider of vendor neutral,
enterprise-wide solutions for unrestricted medical image management.
FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT.
For more information please visit http://www.fujifilmhealthcare.com
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation
and leading-edge products to a broad spectrum of industries, including:
healthcare, with medical systems, pharmaceuticals and cosmetics; graphic
systems; highly functional materials, such as flat panel display
materials; optical devices, such as broadcast and cinema lenses; digital
imaging; and document products. These are based on a vast portfolio of
chemical, mechanical, optical, electronic, software and production
technologies. In the year ended March 31, 2015, the company had global
revenues of $20.8 billion, at an exchange rate of 120 yen to the dollar.
Fujifilm is committed to environmental stewardship and good corporate
citizenship. For more information, please visit: www.fujifilmholdings.com.